Recent DTIL News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 08:51:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/04/2024 08:49:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 12:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:15:08 PM
- Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update • Business Wire • 11/04/2024 12:01:00 PM
- Precision BioSciences to Report Third Quarter Results on November 4, 2024 • Business Wire • 10/29/2024 11:01:00 AM
- Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024 • Business Wire • 10/28/2024 11:01:00 AM
- Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress • Business Wire • 10/24/2024 08:15:00 PM
- Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PBGENE-HBV First-In-Human Study for the Treatment of Chronic Hepatitis B • Business Wire • 10/24/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:45:07 PM
- Precision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences • Business Wire • 10/21/2024 11:01:00 AM
- Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress • Business Wire • 10/16/2024 11:01:00 AM
- Precision BioSciences to Present at the Upcoming H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference • Business Wire • 10/03/2024 11:01:00 AM
- Precision BioSciences Submits First Clinical Trial Applications to Initiate Phase 1 Trial for PBGENE-HBV for the Treatment of Chronic Hepatitis B • Business Wire • 09/30/2024 11:01:00 AM
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/20/2024 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:00:13 PM
- Precision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical Execution • Business Wire • 09/12/2024 11:15:00 AM
- Precision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare Conference • Business Wire • 09/04/2024 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:03:28 PM
- Precision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel Deal • Business Wire • 09/03/2024 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 11:30:02 AM
- Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis • Business Wire • 08/09/2024 11:01:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM